APO Research
Talk to an analyst

APO RESEARCH · REPORT

Voltaren

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Voltaren Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchVoltaren Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Voltaren Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Voltaren Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voltaren Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Voltaren Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Voltaren market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Voltaren market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Voltaren market include Endo Pharmaceuticals, Enovachem Pharmaceuticals, Hainan Quanxing Pharmaceutical, Iroko Pharmaceuticals, Jewim Pharmaceutical, Supor South Ocean, GSK and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Voltaren market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Voltaren and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Voltaren sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Voltaren market size, projected growth trends, production technologies, key applications, and end-use industries.

Voltaren Segment by Company

Endo Pharmaceuticals

Enovachem Pharmaceuticals

Hainan Quanxing Pharmaceutical

Iroko Pharmaceuticals

Jewim Pharmaceutical

Supor South Ocean

GSK

Novartis

Voltaren Segment by Type

Injection

Tablet

Spray

Gel

Capsule

Voltaren Segment by Application

Elderly

Adults

Voltaren Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Voltaren status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Voltaren market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Voltaren significant trends, drivers, influence factors in global and regions.

6. To analyze Voltaren competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voltaren market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voltaren and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voltaren.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Voltaren market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Voltaren industry.

Chapter 3: Detailed analysis of Voltaren manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Voltaren in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Voltaren in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Voltaren Industry Trends Table 2. Voltaren Industry Drivers Table 3. Voltaren Industry Opportunities and Challenges Table 4. Voltaren Industry Restraints Table 5. Global Voltaren Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Voltaren Revenue Share by Company (2021-2026) Table 7. Global Voltaren Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Voltaren Sales Volume Share by Company (2021-2026) Table 9. Global Voltaren Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Voltaren Company Ranking, (2024-2026) & (USD Million) Table 11. Global Voltaren Key Company Manufacturing Base & Headquarters Table 12. Global Voltaren Company, Product Type & Application Table 13. Global Voltaren Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Voltaren by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Tablet Table 19. Significant Companies of Spray Table 20. Significant Companies of Gel Table 21. Significant Companies of Capsule Table 22. Global Voltaren Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Voltaren Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Voltaren Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Voltaren Sales Volume Share by Type (2021-2026) Table 26. Global Voltaren Sales Volume Share by Type (2027-2032) Table 27. Global Voltaren Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Voltaren Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Voltaren Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Voltaren Sales Value Share by Type (2021-2026) Table 31. Global Voltaren Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Elderly Table 33. Significant Companies of Adults Table 34. Global Voltaren Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Voltaren Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Voltaren Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Voltaren Sales Volume Share by Application (2021-2026) Table 38. Global Voltaren Sales Volume Share by Application (2027-2032) Table 39. Global Voltaren Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Voltaren Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Voltaren Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Voltaren Sales Value Share by Application (2021-2026) Table 43. Global Voltaren Sales Value Share by Application (2027-2032) Table 44. Global Voltaren Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Voltaren Sales by Region (2021-2026) & (K Units) Table 46. Global Voltaren Sales Market Share by Region (2021-2026) Table 47. Global Voltaren Sales by Region (2027-2032) & (K Units) Table 48. Global Voltaren Sales Market Share by Region (2027-2032) Table 49. Global Voltaren Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Voltaren Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Voltaren Sales Value Share by Region (2021-2026) Table 52. Global Voltaren Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Voltaren Sales Value Share by Region (2027-2032) Table 54. Global Voltaren Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Voltaren Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Voltaren Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Voltaren Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Voltaren Sales by Country (2021-2026) & (K Units) Table 59. Global Voltaren Sales Market Share by Country (2021-2026) Table 60. Global Voltaren Sales by Country (2027-2032) & (K Units) Table 61. Global Voltaren Sales Market Share by Country (2027-2032) Table 62. Global Voltaren Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Voltaren Sales Value Market Share by Country (2021-2026) Table 64. Global Voltaren Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Voltaren Sales Value Market Share by Country (2027-2032) Table 66. Endo Pharmaceuticals Company Information Table 67. Endo Pharmaceuticals Business Overview Table 68. Endo Pharmaceuticals Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Endo Pharmaceuticals Voltaren Product Portfolio Table 70. Endo Pharmaceuticals Recent Development Table 71. Enovachem Pharmaceuticals Company Information Table 72. Enovachem Pharmaceuticals Business Overview Table 73. Enovachem Pharmaceuticals Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Enovachem Pharmaceuticals Voltaren Product Portfolio Table 75. Enovachem Pharmaceuticals Recent Development Table 76. Hainan Quanxing Pharmaceutical Company Information Table 77. Hainan Quanxing Pharmaceutical Business Overview Table 78. Hainan Quanxing Pharmaceutical Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hainan Quanxing Pharmaceutical Voltaren Product Portfolio Table 80. Hainan Quanxing Pharmaceutical Recent Development Table 81. Iroko Pharmaceuticals Company Information Table 82. Iroko Pharmaceuticals Business Overview Table 83. Iroko Pharmaceuticals Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Iroko Pharmaceuticals Voltaren Product Portfolio Table 85. Iroko Pharmaceuticals Recent Development Table 86. Jewim Pharmaceutical Company Information Table 87. Jewim Pharmaceutical Business Overview Table 88. Jewim Pharmaceutical Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jewim Pharmaceutical Voltaren Product Portfolio Table 90. Jewim Pharmaceutical Recent Development Table 91. Supor South Ocean Company Information Table 92. Supor South Ocean Business Overview Table 93. Supor South Ocean Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Supor South Ocean Voltaren Product Portfolio Table 95. Supor South Ocean Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GSK Voltaren Product Portfolio Table 100. GSK Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis Voltaren Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Novartis Voltaren Product Portfolio Table 105. Novartis Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Voltaren Distributors List Table 109. Voltaren Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Voltaren Product Image Figure 2. Global Voltaren Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voltaren Sales Value (2021-2032) & (US$ Million) Figure 4. Global Voltaren Sales (2021-2032) & (K Units) Figure 5. Global Voltaren Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Voltaren Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Tablet Image Figure 11. Spray Image Figure 12. Gel Image Figure 13. Capsule Image Figure 14. Global Voltaren Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Voltaren Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Voltaren Sales Volume Share by Type (2021-2032) Figure 17. Global Voltaren Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Voltaren Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Voltaren Sales Value Share by Type (2021-2032) Figure 20. Elderly Image Figure 21. Adults Image Figure 22. Global Voltaren Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Voltaren Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Voltaren Sales Volume Share by Application (2021-2032) Figure 25. Global Voltaren Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Voltaren Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Voltaren Sales Value Share by Application (2021-2032) Figure 28. Global Voltaren Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Voltaren Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Voltaren Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Voltaren Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Voltaren Sales Value (2021-2032) & (US$ Million) Figure 33. North America Voltaren Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Voltaren Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Voltaren Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Voltaren Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Voltaren Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Voltaren Sales Value (2021-2032) & (US$ Million) Figure 39. South America Voltaren Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Voltaren Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Voltaren Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Voltaren Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Voltaren Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Voltaren Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Voltaren Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Voltaren Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Spray
  • Gel
  • Capsule
Applications
  • Elderly
  • Adults
Companies covered
  • Endo Pharmaceuticals
  • Enovachem Pharmaceuticals
  • Hainan Quanxing Pharmaceutical
  • Iroko Pharmaceuticals
  • Jewim Pharmaceutical
  • Supor South Ocean
  • GSK
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Voltaren Sales Value (2021-2032)
  4. 1.2.2 Global Voltaren Sales Volume (2021-2032)
  5. 1.2.3 Global Voltaren Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Voltaren Market Dynamics
  1. 2.1 Voltaren Industry Trends
  2. 2.2 Voltaren Industry Drivers
  3. 2.3 Voltaren Industry Opportunities and Challenges
  4. 2.4 Voltaren Industry Restraints
3 Voltaren Market by Company
  1. 3.1 Global Voltaren Company Revenue Ranking in 2025
  2. 3.2 Global Voltaren Revenue by Company (2021-2026)
  3. 3.3 Global Voltaren Sales Volume by Company (2021-2026)
  4. 3.4 Global Voltaren Average Price by Company (2021-2026)
  5. 3.5 Global Voltaren Company Ranking (2024-2026)
  6. 3.6 Global Voltaren Company Manufacturing Base and Headquarters
  7. 3.7 Global Voltaren Company Product Type and Application
  8. 3.8 Global Voltaren Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Voltaren Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Voltaren Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Voltaren Market by Type
  1. 4.1 Voltaren Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablet
  4. 4.1.3 Spray
  5. 4.1.4 Gel
  6. 4.1.5 Capsule
  7. 4.2 Global Voltaren Sales Volume by Type
  8. 4.2.1 Global Voltaren Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Voltaren Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Voltaren Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Voltaren Sales Value by Type
  12. 4.3.1 Global Voltaren Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Voltaren Sales Value by Type (2021-2032)
  14. 4.3.3 Global Voltaren Sales Value Share by Type (2021-2032)
5 Voltaren Market by Application
  1. 5.1 Voltaren Application Introduction
  2. 5.1.1 Elderly
  3. 5.1.2 Adults
  4. 5.2 Global Voltaren Sales Volume by Application
  5. 5.2.1 Global Voltaren Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Voltaren Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Voltaren Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Voltaren Sales Value by Application
  9. 5.3.1 Global Voltaren Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Voltaren Sales Value by Application (2021-2032)
  11. 5.3.3 Global Voltaren Sales Value Share by Application (2021-2032)
6 Voltaren Regional Sales and Value Analysis
  1. 6.1 Global Voltaren Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Voltaren Sales by Region (2021-2032)
  3. 6.2.1 Global Voltaren Sales by Region: 2021-2026
  4. 6.2.2 Global Voltaren Sales by Region (2027-2032)
  5. 6.3 Global Voltaren Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Voltaren Sales Value by Region (2021-2032)
  7. 6.4.1 Global Voltaren Sales Value by Region: 2021-2026
  8. 6.4.2 Global Voltaren Sales Value by Region (2027-2032)
  9. 6.5 Global Voltaren Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Voltaren Sales Value (2021-2032)
  12. 6.6.2 North America Voltaren Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Voltaren Sales Value (2021-2032)
  15. 6.7.2 Europe Voltaren Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Voltaren Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Voltaren Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Voltaren Sales Value (2021-2032)
  21. 6.9.2 South America Voltaren Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Voltaren Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Voltaren Sales Value Share by Country, 2025 VS 2032
7 Voltaren Country-level Sales and Value Analysis
  1. 7.1 Global Voltaren Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Voltaren Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Voltaren Sales by Country (2021-2032)
  4. 7.3.1 Global Voltaren Sales by Country (2021-2026)
  5. 7.3.2 Global Voltaren Sales by Country (2027-2032)
  6. 7.4 Global Voltaren Sales Value by Country (2021-2032)
  7. 7.4.1 Global Voltaren Sales Value by Country (2021-2026)
  8. 7.4.2 Global Voltaren Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Voltaren Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Voltaren Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Voltaren Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Voltaren Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Voltaren Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Voltaren Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Voltaren Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Voltaren Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Voltaren Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Voltaren Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Voltaren Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Voltaren Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Voltaren Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Voltaren Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Voltaren Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Voltaren Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Voltaren Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Voltaren Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Voltaren Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Voltaren Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Voltaren Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Voltaren Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Voltaren Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Voltaren Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Voltaren Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Voltaren Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Voltaren Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Voltaren Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Voltaren Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Voltaren Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Voltaren Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Voltaren Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Voltaren Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Voltaren Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Voltaren Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Voltaren Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Voltaren Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Voltaren Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Voltaren Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Voltaren Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Voltaren Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Voltaren Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Voltaren Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Voltaren Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Voltaren Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Voltaren Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Voltaren Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Voltaren Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Voltaren Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Voltaren Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Voltaren Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Voltaren Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Voltaren Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Voltaren Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Voltaren Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Voltaren Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Voltaren Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Voltaren Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Voltaren Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Voltaren Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Voltaren Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Voltaren Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Voltaren Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Voltaren Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Voltaren Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Voltaren Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Voltaren Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Voltaren Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Voltaren Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Voltaren Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Voltaren Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Voltaren Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Voltaren Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Voltaren Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Voltaren Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Voltaren Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Voltaren Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Voltaren Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Voltaren Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Voltaren Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Voltaren Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Voltaren Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Voltaren Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Voltaren Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Endo Pharmaceuticals
  2. 8.1.1 Endo Pharmaceuticals Company Information
  3. 8.1.2 Endo Pharmaceuticals Business Overview
  4. 8.1.3 Endo Pharmaceuticals Voltaren Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Endo Pharmaceuticals Voltaren Product Portfolio
  6. 8.1.5 Endo Pharmaceuticals Recent Developments
  7. 8.2 Enovachem Pharmaceuticals
  8. 8.2.1 Enovachem Pharmaceuticals Company Information
  9. 8.2.2 Enovachem Pharmaceuticals Business Overview
  10. 8.2.3 Enovachem Pharmaceuticals Voltaren Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Enovachem Pharmaceuticals Voltaren Product Portfolio
  12. 8.2.5 Enovachem Pharmaceuticals Recent Developments
  13. 8.3 Hainan Quanxing Pharmaceutical
  14. 8.3.1 Hainan Quanxing Pharmaceutical Company Information
  15. 8.3.2 Hainan Quanxing Pharmaceutical Business Overview
  16. 8.3.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Quanxing Pharmaceutical Voltaren Product Portfolio
  18. 8.3.5 Hainan Quanxing Pharmaceutical Recent Developments
  19. 8.4 Iroko Pharmaceuticals
  20. 8.4.1 Iroko Pharmaceuticals Company Information
  21. 8.4.2 Iroko Pharmaceuticals Business Overview
  22. 8.4.3 Iroko Pharmaceuticals Voltaren Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Iroko Pharmaceuticals Voltaren Product Portfolio
  24. 8.4.5 Iroko Pharmaceuticals Recent Developments
  25. 8.5 Jewim Pharmaceutical
  26. 8.5.1 Jewim Pharmaceutical Company Information
  27. 8.5.2 Jewim Pharmaceutical Business Overview
  28. 8.5.3 Jewim Pharmaceutical Voltaren Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jewim Pharmaceutical Voltaren Product Portfolio
  30. 8.5.5 Jewim Pharmaceutical Recent Developments
  31. 8.6 Supor South Ocean
  32. 8.6.1 Supor South Ocean Company Information
  33. 8.6.2 Supor South Ocean Business Overview
  34. 8.6.3 Supor South Ocean Voltaren Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Supor South Ocean Voltaren Product Portfolio
  36. 8.6.5 Supor South Ocean Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Voltaren Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GSK Voltaren Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Voltaren Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Voltaren Product Portfolio
  48. 8.8.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Voltaren Value Chain Analysis
  2. 9.1.1 Voltaren Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Voltaren Sales Mode & Process
  6. 9.2 Voltaren Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Voltaren Distributors
  9. 9.2.3 Voltaren Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst